Impact of COVID-19 restrictions on childhood allergic sensitization: a three-phase comparative study

Wenxia Shao1, Qingyi Shao2

  • 1Department of Laboratory Medicine, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, China.

Scientific Reports
|November 13, 2025
PubMed

Insights

COVID-19 restrictions influenced children's allergen sensitivity. While restrictions lowered allergy prevalence, lifting them and subsequent COVID-19 surges saw increased allergic disease activity.

Area of Science:

  • Pediatric Allergy and Immunology
  • Epidemiology of Allergic Diseases
  • Impact of Public Health Interventions

Background:

  • The COVID-19 pandemic and associated restrictions significantly altered daily life, potentially impacting the prevalence and severity of allergic diseases in children.
  • Understanding these changes is crucial for managing pediatric allergic conditions in evolving public health landscapes.

Purpose of the Study:

  • To investigate the influence of COVID-19 restrictions and subsequent deregulation on allergen sensitivity and allergic disease activity in children.
  • To analyze changes in allergen-specific immunoglobulin E (sIgE) positivity, levels, and polysensitization patterns.

Main Methods:

  • Retrospective analysis of pediatric patients undergoing allergen testing before deregulation, after deregulation, and during the corresponding period in 2021.
  • Evaluation of allergen-specific IgE (sIgE) positivity rates, IgE levels, and polysensitization.
  • Statistical analysis of changes in allergy prevalence and disease activity.

Main Results:

  • A decrease in pediatric allergy visits was observed post-deregulation compared to pre-deregulation and 2021 periods.
  • Allergen positivity rates and sIgE levels were lower post-deregulation than pre-deregulation, but higher than in 2021.
  • The correlation between milk and beef sensitivity weakened post-deregulation compared to pre-deregulation, but strengthened compared to 2021.

Conclusions:

  • COVID-19 restrictions were associated with reduced allergic disease activity in children.
  • Lifting restrictions and subsequent COVID-19 surges correlated with an increase in allergic disease activity compared to the 2021 period.
  • These findings highlight the dynamic relationship between environmental factors, public health measures, and pediatric allergic conditions.

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
31.9K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
375
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.2K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.0K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K